Robert J. Flanagan, Director at Sagent Pharmaceuticals, Inc. (SGNT), sold 16,000 shares at $27.07 ($435K) on 2014-08-28, disclosed to the SEC on 2014-08-29.
Scheduled sale ($435k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.30 | 8,000 | $218K | 50.2% |
| 2 | $27.07 | 8,000 | $217K | 49.8% |
| Total | $27.18 avg | 16,000 | $435K | 100% |
| Filing → |
| SGNT | SELL | 2014-10-08 | $505K | — | Filing → |
| SGNT | SELL | 2014-09-25 | $480K | — | Filing → |
| SGNT | SELL | 2014-09-12 | $453K | — | Filing → |